Original Article

You have full text access to this OnlineOpen article

Development of an ovarian cancer symptom index†

Possibilities for earlier detection

  1. Barbara A. Goff MD1,2,‡,*,
  2. Lynn S. Mandel PhD1,2,
  3. Charles W. Drescher MD2,
  4. Nicole Urban ScD2,3,
  5. Shirley Gough BSN2,
  6. Kristi M. Schurman BA2,
  7. Joshua Patras BS2,
  8. Barry S. Mahony MD4,
  9. M. Robyn Andersen PhD2,3

Article first published online: 11 DEC 2006

DOI: 10.1002/cncr.22371

Issue

Cancer

Cancer

Volume 109, Issue 2, pages 221–227, 15 January 2007

Additional Information

How to Cite

Goff, B. A., Mandel, L. S., Drescher, C. W., Urban, N., Gough, S., Schurman, K. M., Patras, J., Mahony, B. S. and Andersen, M. R. (2007), Development of an ovarian cancer symptom index. Cancer, 109: 221–227. doi: 10.1002/cncr.22371

Author Information

  1. 1

    Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, Washington

  2. 2

    Molecular Diagnostic Program, Fred Hutchinson Cancer Research Center, Seattle, Washington

  3. 3

    University of Washington School of Public Health, Seattle, Washington

  4. 4

    Seattle Ultrasound Associates, Seattle, Washington

  1. ‡

    Fax: (206) 543-3915.

*Department of Obstetrics and Gynecology, University of Washington School of Medicine, 1959 NE Pacific Street, BB625, Box 356460, Seattle, WA 98196–6460

  1. †

    The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the Marsha Rivkin Center for Ovarian Cancer Research or the National Cancer Institute.

Publication History

  1. Issue published online: 8 JAN 2007
  2. Article first published online: 11 DEC 2006
  3. Manuscript Accepted: 9 OCT 2006
  4. Manuscript Revised: 4 OCT 2006
  5. Manuscript Received: 11 SEP 2006

Funded by

  • Marsha Rivkin Center for Ovarian Cancer Research (Seattle, WA)
  • National Institutes of Health/National Cancer Institute. Grant Number: P50 CA83636 to N
  • Urban (“Pacific Ovarian Cancer Research Consortium: Specialized Program of Research Excellence in Ovarian Cancer.”)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (266K)

REFERENCES

  • 1
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106–130.
    Direct Link:
  • 2
    Ozols RF, Rubin SC, Thomas GM, Robboy S. Epithelial ovarian cancer. In: HoskinsWJ, PerezCA, YoungR, BarakatR, et al, eds. Principles and Practice of Gynecologic Oncology. 4th ed, Philadelphia, Pa: Lippincott Williams & Wilkins; 2005: 895–987.
  • 3
    Goff BA, Muntz HG. Screening and early diagnosis of ovarian cancer. Womens Health Primary Care. 2005; 8: 262–268.
  • 4
    Menon U, Jacobs IJ, Ovarian cancer screening in the general population. Curr Opin Obstet Gynecol. 2001; 13: 61–64.
  • 5
    Paley PJ. Ovarian cancer screening: are we making any progress? Curr Opin Oncol. 2001; 13: 399–402.
  • 6
    Van Nagell JRJr, DePriest PD, Reedy MB, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol. 2000; 77: 350–356.
  • 7
    Jacobs I, Davies ASP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 1993; 306: 1030–1034.
  • 8
    Liede A, Karlan BY, Baldwin RL, et al. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol. 2002; 20: 1570–1577.
  • 9
    Fishman DA, Cohen L, Blank SV, et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol. 2005; 192: 1214–1221.
  • 10
    Skates SJ, Horick N, Yu Y, et al. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factory using mixtures of multivariate normal distributions. J Clin Oncol. 2004; 22: 4059–4066.
  • 11
    Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002; 3: 355–366.
  • 12
    Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004; 3: 355–366.
  • 13
    National Institutes of Health. Consensus Development Conference Statement. Ovarian cancer: screening, treatment and follow-up. Gynecol Oncol. 1994; 55(3 pt 2): S4–S14.
  • 14
    [No authors listed.] American College of Obstetrics and Gynecology. Committee opinion: routine cancer screening. Int J Gynecol Obstet. 1997; 59: 157–161.
  • 15
    US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing; 1996.
  • 16
    Goff BA, Mandel LS, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer. 2000; 89: 2068–2075.
    Direct Link:
  • 17
    Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004; 291: 2705–2712.
  • 18
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychological Meas. 1977; 1: 385–401.
  • 19
    Watson D, Clark LA, Tellegen A. Development and validation of brief measure of positive and negative affect: the PANAS scale. J Pers Soc Psychol. 1988; 54: 1063–1070.
  • 20
    Young RC. Gynecologic malignancies. In: FauciAS, BraunwaldE, IsselbacherKJ, WilsonJD, MartinJB, KasperDL, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998: 605–611.
  • 21
    Clement KD, Connor PD. Tumors of the female reproductive organs. In: TaylorRB, DavidAK, JohnsonTAJr, PhillipsDM, SchergerJE, eds. Family Medicine: Principles and Practice. 5th ed. New York, NY: Springer-Verlag, Inc.; 1998: 916–924.
  • 22
    American College of Obstetricians and Gynecologists. 1999 Compendium of Selected Publications. ACOG Educational Bulletin no. 250. Washington DC: American College of Obstetricians and Gynecologists; 1998: 665–673.
  • 23
    Olson SH, Mignone L, Nakraseive C, et al. Symptoms of ovarian cancer. Obstet Gynecol. 2001; 98: 212–217.
  • 24
    Olivier RI, Lubsen-Brandsma MA, Berhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol. 2006; 100: 20–26.
  • 25
    Croyle RT, Uretsky MB. Effects of mood on self-appraisal of health status. Health Psychol. 1987; 6: 239–253.
  • 26
    Smith LH, Morris CR, Yasmeen S, Parikh-Patel A, Cress RD, Romano PS. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer. 2005; 104: 1398–1407.
    Direct Link:
  • 27
    Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994; 170: 974–979.
  • 28
    Hoskins WJ. Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol. 1994; 55(3 Pt 2): S91–S96.
View Full Article (HTML) Get PDF (266K)